Table 2. Characteristics and outcomes of HF patients.
INTERMACS score, the type of HF, LVAD device type, and outcomes for HF patients are shown below. Data are N (%) unless otherwise specified.
| HF Patients (n=32) | |
|---|---|
| INTERMACS score, mean ±SEM | |
| 2 | 12 (±37.5) |
| 3 | 14 (±43.8) |
| 4 | 6 (±18.8) |
| Type of Heart Failure | |
| ICM | 13 (40.6) |
| DCM | 4 (12.5) |
| INICM | 1 (3.1) |
| NCIM | 2 (6.3) |
| IDCM | 10 (31.3) |
| NIDCM | 1 (3.1) |
| NI+ISCCM | 1 (3.1) |
| Device Type | |
| HeartMateII | 20 (62.5) |
| HeartWare HVAD | 8 (25) |
| Jarvik 2000 | 3 (9.4) |
| BiVADs | 1 (3.1) |
| Purpose | |
| Bridge-to-Transplant | 20 (68.7) |
| Destination Therapy | 10 (31.3) |
| Other | 2 (6.3) |
| Anticoagulation Therapy | 29 (90.6) |
| Post-operative Complications | |
| Bleeding | 15 |
| Stroke | 5 |
| Pump Thrombosis | 3 |
| Hemorrhage | 1 |
| Multiorgan Dysfunction | 1 |
| Mortality | 5 (15.6) |